艾媒咨询 | 2025年中国医用分子筛制氧行业发展白皮书

需求增长驱动医用分子筛制氧市场扩容，技术创新将推动行业向智能化、绿色化、高端化迈进。iiMedia Research（艾媒咨询）数据显示，2024年中国医用分子筛制氧机市场规模约4.25亿元，预计2029年将进一步攀升至7.06亿元。随着人口老龄化的加剧、公众健康意识的提高，以及医疗需求的增加，中国医用分子筛制氧机市场的规模在稳步扩大。同时，国家对医疗健康产业的重视程度不断提升，加之环保和新能源等领域的发展，医用分子筛制氧机在工业、医疗和家用等多个领域的应用正不断拓展。
Demand growth drives the expansion of the medical molecular sieve oxygen production market, and technological innovation will promote the industry to become intelligent, green and high-end. iiMedia Research data show that in 2024, the market size of China's medical molecular sieve oxygen generator is about 425 million yuan, and it is expected to further climb to 706 million yuan in 2029. With the increasing aging of the population, the improvement of public health awareness and the increase of medical demand, the scale of China's medical molecular sieve oxygen generator market is steadily expanding. At the same time, the state's attention to the medical and health industry continues to improve, coupled with the development of environmental protection and new energy and other fields, medical molecular sieve oxygen generator in industrial, medical and household applications are constantly expanding.

艾媒报告|2020H1后疫时代全球呼吸机等医疗器械产品监测及企业案例报告

本报告研究涉及企业/品牌/案例：美敦力，GE医疗，迈瑞医疗，万孚生物，鱼跃医疗，乐普医疗，九安医疗；其他提及企业/品牌：冠昊生物，华海药业，金域医学，卫宁健康，新和成，健帆生物，费森尤斯医疗，嘉德诺，丹纳赫，史赛克，依视路陆逊梯卡，创业慧康，康恩贝，华北制药，通用电气，西门子，飞利浦，3M，绿盾，霍尼韦尔，保为康POWECOM，CM朝美，UVEX优唯斯，南丁，云南白药，维康WECAN，振德医疗，迪卡侬，锐步，速尔，爱康，KEEP，李宁，亿健，舒华，WALKINGPAD，英派斯，SKG，本博，倍轻松，南极人，凯仕乐，佳仁，茗振，小熊，璐瑶，攀高

2020年4月21日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020H1后疫时代全球呼吸机等医疗器械产品监测及企业案例报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对全球范围内的医疗器械产品进行全面分析，并且报告聚焦于疫情问题下的呼吸机、额温枪等医疗器械，具体针对美敦力、GE医疗、迈瑞医疗、万孚生物、鱼跃医疗和乐普医疗等典型案例分析，对2020-2021年医疗器械行业发展进行趋势预判。特别在全球新冠肺炎疫情的严峻情势下，呼吸机、额温枪等医疗器械需求猛增，飞利浦、美敦力等西方医疗器械企业快速提高产量，以支持抗疫工作的迫切需求；同时，中国呼吸机等医疗器械企业的海外业务量有明显增长。艾媒咨询分析师认为，全球疫情势必带动医疗器械行业发展，但中国企业应当在保证自身产品质量的基础上抓住机遇，实现业务出海。

According to the data, the global medical device market has continued to increase in size since 2016, and the global medical device market is expected to reach USD 477.4 billion in 2020. Especially under the influence of the New Crown epidemic, the global demand for medical equipment such as ventilators and oxygen concentrators has increased dramatically. Overseas orders for Chinese medical device companies have skyrocketed. Within a certain period, the concept stocks of ventilator in the A-share market have risen.

艾媒报告|2020-2021年中国医疗电商行业发展趋势及标杆企业分析报告

本报告研究涉及企业/品牌/案例：平安好医生,康爱多,阿里健康,健客,鱼跃医疗；其他提及企业/品牌：益药购,1药网,九州通网,心诺,我的医药网,好药师,美之氧,药京采,七乐康,欧姆龙,普天药城网,氧生活,未名企鹅,爱康多,巨人,药药好,京东大药房,康祝,药品终端网,360好药,可孚,药师帮,药房网,艾润科技,药便宜,八百方

2020年3月9日，全球知名的新经济产业第三方数据挖掘和分析机构iiMedia Research(艾媒咨询) 发布《2020-2021年中国医疗电商行业发展趋势及标杆企业分析报告》。报告根据艾媒数据中心、艾媒咨询商业情报数据库、艾媒商情舆情数据监测系统基础数据，对2020年中国医疗电商产业发展进行分析。本报告主要通过医药电商和家用医疗器械两方面，对医疗电商产业上下游深入探究运行模式，并对鱼跃集团、平安好医生、爱康多等典型企业进行案例分析，以此对中国医疗电商行业发展进行趋势预判。2019年中国医药电商行业发展规模继续增大，涌现出许多新型零售方式。越来越多医药企业涌入B2B主流市场，B2C市场规模也随着消费者健康意识的提升以及网购消费习惯的固定而得到较大发展；越来越多药企也开始开展O2O业务。以药到医、“医+药”发展的模式也受到普遍认可。特别在新型冠状病毒肺炎疫情影响下，医疗电商以其独特的互联网优势在抗击疫情中发挥了重要作用。在此契机下，医疗电商行业将在2020年迎来重大普及发展的历史机遇期。

In 2019, the scale of China's pharmaceutical e-commerce industry continues to increase, and many new retail methods have emerged. More and more pharmaceutical companies have entered the mainstream B2B market, and the scale of the B2C market has also grown significantly with the improvement of consumers' health awareness and the fixation of online shopping consumption habits; more and more pharmaceutical companies have begun to develop O2O business. The development model from medicine to medicine and "medicine + medicine" has also been widely recognized. Especially under the influence of the new coronavirus pneumonia epidemic, medical e-commerce has played an important role in fighting the epidemic with its unique Internet advantage. With this opportunity, the medical e-commerce industry will usher in a period of historical opportunities for significant popularization in 2020.